Starting next week, vaccination for clients receiving care under the Long-Term Care Act (WLZ), who are living in small-scale residential facilities without an institutional physician, will be expanded to include the Pfizer/BioNTech vaccine as well as the Moderna vaccine. As a result, much of the target group can be vaccinated sooner. In total, this affects 77,000 people living in small-scale residential facilities. The first people in this group were vaccinated on 25 January.
Due to the limited availability of the Moderna vaccine, it has been decided to use the Pfizer/BioNTech vaccine for this target group as well. From next week on, one of the two vaccines will be administered in this context. By making both vaccines available, this vulnerable group can be vaccinated more quickly. The people living in small-scale residential facilities will be vaccinated by mobile teams deployed from out-of-hours medical centres. They will be vaccinated in their own residential environment.
First vaccines administered to this group on 25 January
Over the past two weeks, the first vaccines were administered to people receiving care under the Long-Term Care Act (WLZ) who live in a small-scale residential facility. This covered nearly 5,000 people who were vaccinated by mobile teams from four out-of-hours medical centres. Nearly 6,000 more people will be added this week. They are being vaccinated by six out-of-hours medical centres in different locations in the Netherlands.